Johanna Meyer, Carl Zeiss Meditec AG (F), Heidelberg Engineering (F);
Petra Fang, Heidelberg Engineering (F);
Tim Krohne, Alimera Sciences (C), Alimera Sciences (F), Bayer HealthCare (C), Bayer HealthCare (R), Heidelberg Engineering (F), Heidelberg Engineering (R), Novartis (F), Novartis (R), Novartis (C);
Frank Holz, Acucela (F), Acucela (C), Allergan (F), Allergan (R), Bayer HealthCare (F), Bayer HealthCare (C), Bayer HealthCare (R), Bioeq (F), Bioeq (C), Boehringer-Ingelheim (C), Carl Zeiss Meditec (F), Genentech/Roche (F), Genentech/Roche (C), Genentech/Roche (R), Heidelberg Engineering (C), Heidelberg Engineering (R), Heidelberg Engineering (F), Merz (C), NightstarX (F), Novartis (F), Novartis (C), Novartis (R), Optos (F), Pixium (F), Thea (C);
Steffen Schmitz-Valckenberg, Alcon/Novartis (F), Alcon/Novartis (C), Allergan (F), Allergan (R), Bayer HealthCare (F), Bayer HealthCare (R), Carl Zeiss MediTec (F), Formycon (F), Genentech/Roche (F), Genentech/Roche (C), Genentech/Roche (R), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F)